Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights

Received authorization from the U.S. FDA and approval from the European Commission for the Company's updated COVID-19 vaccine, and launched the only...

Related Keywords

New Zealand ,Australia ,Taiwan ,Canada ,India ,Singapore ,Erika Schultz ,Ali Chartan ,Johnc Jacobs ,Drug Administration ,Stop Shop ,Leverage Technology Platform ,Serum Life Sciences ,Linkedin ,Prnewswire Novavax Inc ,Exchange Commission ,World Health Organization ,Novavax Inc ,Costco ,Rite Aid ,Serum Institute Of India Pvt ,Nasdaq ,European Commission For The Company ,Pharma Services ,Publix ,European Commission ,Influenza Combination ,Chief Executive Officer ,Emergency Use Authorization ,Reduce Rate ,Manage Cash Flow ,Evolve Scale ,Drive Additional Value Beyond Nuvaxovid ,Full Year ,First Quarter ,Matrixm Malaria ,License Application ,Serum Institute ,Serum Life Sciences Limited ,Financial Condition ,Annual Report ,Quarterly Reports ,Novavax ,Nc ,